DEFA14A ·Filed Apr 24, 2026

SBRA

Sabra Health Care REIT, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001193125-26-175401
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual meeting with no surprises. Monitor the voting results for any unexpected opposition to director elections or executive pay, which could signal shareholder discontent, but none is anticipated based on the filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SBRA ▲ +9.71% at T+60d
NEUTRAL call ✓ call won +9.71% · α vs SPY +4.63% · entry $20.09 → $22.04
Entry anchored
Apr 23, 03:59 PM ET
via exchange tick
T+1d
+1.00%
call +1.00% · α +0.83%
$20.29
settled 5mo ago
T+5d
+2.84%
call +2.84% · α +1.93%
$20.66
settled 5mo ago
T+20d
+3.09%
call +3.09% · α -0.94%
$20.71
settled 4mo ago
T+60d
+9.71%
call +9.71% · α +4.63%
$22.04
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Sabra Health Care REIT is holding its annual shareholder meeting to vote on the re-election of seven directors, ratification of its auditor PricewaterhouseCoopers, and an advisory vote on executive compensation. The filing is a routine proxy statement with no activist involvement or contested proposals.

Key Facts

  • Seven director nominees: Craig A. Barbarosh, Katie Cusack, Michael J. Foster, Lynne S. Katzmann, Ann Kono, Jeffrey A. Malehorn, Richard K. Matros
  • Proposal to ratify PricewaterhouseCoopers as independent auditor for 2026
  • Advisory vote on compensation of named executive officers
  • Meeting date: June 17, 2026

Financial Impact

No direct financial impact from the vote; routine corporate governance

board compositionauditor relationshipexecutive compensation

Risk Factors

  • Low risk of shareholder revolt on any proposal
  • No material governance changes expected

Market Snapshot

Exchange
Nasdaq
Sector
Real Estate Investment Trusts

Investment Themes

Real Estate

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-175401
Document: 0001193125-26-175401-index-headers.html0001193125-26-175401
Document: 0001193125-26-175401-index.html0001193125-26-175401
Document: 0001193125-26-175401.txt0001193125-26-175401
2 reports for SBRA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SBRA — sortable, filterable
TypeNow
Jul 21, 2026
10w ago
8-K
BULLISH ★ 7/10
$22.04 $20.33▼ −7.76%▼ −10.32%$19.16 (−13.07%)
Apr 24, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$20.09 $20.71▲ +3.09%▼ −0.94%$19.16 (−4.63%)
Showing 2 of 2

US Market Status

Market Closed — Opens Mon (64h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access